US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Roquefort Therapeutics plc

0.0214

0.0000

Volume:- -

Turnover:- -

Market Cap:3.36M

PE:-2.27

High:0.0214

Open:0.0214

Low:0.0214

Close:0.0214

52wk High:0.0214

52wk Low:0.0214

Shares:157.44M

Float Shares:100.67M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0094

EPS(LYR):-0.0094

ROE:-18.23%

ROA:-9.93%

PB:0.53

PE(LYR):-2.28

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Roquefort Therapeutics plc

Exchange:

PINK LIMITED

Establishment Date:

2020

Employees:

7

Office Location:

85 Great Portland Street,First Floor,London,Greater London,United Kingdom

Website:

http://www.roquefortplc.com

Zip Code:

W1W 7LT

Phone:

44 20 3918 8633

Fax:

- -

Introduction:

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ROQAF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ROQAF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROQAF\",,,,,undefined,":{"symbol":"ROQAF","market":"US","secType":"STK","nameCN":"Roquefort Therapeutics plc","latestPrice":0.02135,"timestamp":1765314000000,"preClose":0.02135,"halted":0,"volume":0,"delay":15,"floatShares":100671476,"shares":157444030,"eps":-0.009389,"marketStatus":"Closed","change":0,"latestTime":"12-09 16:00:00 EST Delay","open":0.02135,"high":0.02135,"low":0.02135,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.009389,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765357200000},"marketStatusCode":5,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.02135,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROQAF\",,,,,undefined,":{"symbol":"ROQAF","floatShares":100671476,"roa":"-9.93%","roe":"-18.23%","lyrEps":-0.009356,"shares":157444030,"dividePrice":0,"high":0.02135,"amplitude":0,"preClose":0.02135,"low":0.02135,"week52Low":0.02135,"pbRate":"0.53","week52High":0.02135,"institutionHeld":0,"latestPrice":0.02135,"eps":-0.009389,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.009389,"open":0.02135,"prevYearClose":0.05,"prevWeekClose":0.0214,"prevMonthClose":0.0214,"prevQuarterClose":0.0214,"fiveDayClose":0.0214,"twentyDayClose":0.0214,"sixtyDayClose":0.0214},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROQAF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-26","symbol":"ROQAF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714104000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2023-09-27","symbol":"ROQAF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1695787200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-09-23","symbol":"ROQAF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1663905600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROQAF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROQAF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":694137747,"yearFounded":2020,"employeeNum":7,"address":"85 Great Portland Street,First Floor,London,Greater London,United Kingdom","zipCode":"W1W 7LT","officePhone":"44 20 3918 8633"},"stockCompanyDetail":{"websiteUrl":"http://www.roquefortplc.com","description":"Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.","exchange":"PINK LIMITED","name":"Roquefort Therapeutics plc","nameEN":"Roquefort Therapeutics plc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ROQAF\",market:\"US\",,,undefined,":null}}